Medpace Holdings Inc (MEDP) Stock Analysis

Sector: HEALTHCARE - DIAGNOSTICS & RESEARCH

Exchange: NASDAQ

Key Metrics

• Price: $447.09
• Market Cap: $12.43B
• P/E Ratio: 28.65
• EPS: $15.29
• 52-Week High: $628.92
• 52-Week Low: $250.05

Market Sentiment

Medpace Holdings Inc currently has a Neutral sentiment score of -0.11.

About Medpace Holdings Inc

Medpace Holdings, Inc. is a global leader in providing comprehensive clinical research services for pharmaceutical, biotechnology, and medical device companies. Headquartered in Cincinnati, Ohio, the firm operates across North America, Europe, and Asia, offering expertise in every phase of the clinical development process. Medpace stands out for its commitment to high-quality execution and regulatory compliance, enabling clients to effectively advance their products from development through t...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Medpace Holdings Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does MEDP pay dividends?

Medpace Holdings Inc (MEDP) does not currently pay a regular dividend.

What is MEDP's P/E ratio?

Medpace Holdings Inc has a price-to-earnings (P/E) ratio of 28.65.

What is MEDP's market cap?

Medpace Holdings Inc (MEDP) has a market capitalization of $12.43B with a current stock price of $447.09.